Videos

The ‘Why’ Behind What We Do

Clinical Research

Marie speaks passionately about her experience, how she felt and what she did after receiving the news that finally, the drug that prolonged her daughter’s life would now be given to other children, and she shares her personal thoughts on the value of a clinical trial.

Videos

PharmaVoice Editor’s Take Video @ DIA 2018

Clinical Research

Watch Peter Benton, COO at Worldwide, as he discusses evolution within the CRO industry, what sponsors look for in a CRO, the importance of partnerships and how company culture impacts innovation and success.

On-Demand Webinars

Moving the Needle on MS Research

Central Nervous System (CNS), Late Phase, Neuroscience

Discover insights from the experts at GeNeuro, a clinical stage pharmaceutical company developing a new approach to the treatment of autoimmune diseases, about the first clinical efficacy study of GNbAC1.

Articles

Optimising MRI in Multiple Sclerosis Drug Development

Neuroscience

The increasing amount of highly effective treatment options in relapsing forms of multiple sclerosis (MS) requires innovative clinical trial design strategies. These strategies may encompass the application of adaptive designs as well as the adoption of innovative primary outcome measurements. Learn more about these trial design strategies in the article below.

Articles

Evolving landscapes in multiple sclerosis research: adaptive designs and novel endpoints

Neuroscience

The increasing amount of highly effective treatment options in relapsing forms of multiple sclerosis (MS) requires innovative clinical trial design strategies. These strategies may encompass the application of adaptive designs as well as the adoption of innovative primary outcome measurements. Learn more about these trial design strategies in the article below.